Poor diagnostic accuracy of commercial antibody-based assays for the diagnosis of acute Chikungunya infection

41Citations
Citations of this article
96Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

A Sri Lankan fever cohort (n = 292 patients; 17.8% prevalence) was used to assess two standard diagnostic Chikungunya IgM tests. The immunochromatographic test (ICT) acute sample sensitivity (SN) was 1.9 to 3.9%, and specificity (SP) was 92.5 to 95.0%. The enzyme-linked immunosorbent assay (ELISA) gave an acute sample SN of 3.9% and an SP of 92.5% and a convalescent sample SN of 84% and an SP of 91%. These assays are not suitable for the acute diagnosis of Chikungunya virus infection. Copyright © 2011, American Society for Microbiology. All Rights Reserved.

Cite

CITATION STYLE

APA

Blacksell, S. D., Tanganuchitcharnchai, A., Jarman, R. G., Gibbons, R. V., Paris, D. H., Bailey, M. S., … De Silva, H. J. (2011). Poor diagnostic accuracy of commercial antibody-based assays for the diagnosis of acute Chikungunya infection. Clinical and Vaccine Immunology, 18(10), 1773–1775. https://doi.org/10.1128/CVI.05288-11

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free